Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases
Crossref DOI link: https://doi.org/10.1007/s11596-018-1984-0
Published Online: 2018-12-07
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ke, Shao-bo
Qiu, Hu
Chen, Jia-mei
Shi, Wei
Chen, Yong-shun
Text and Data Mining valid from 2018-12-01
Article History
Received: 18 April 2018
Revised: 3 July 2018
First Online: 7 December 2018